<?xml version="1.0" encoding="UTF-8"?>
<p>Figure 
 <xref rid="fsn32004-fig-0002" ref-type="fig">2a</xref> shows the HPLC analysis of Peak IV and standard 
 <italic>p</italic>‐coumaric acid ethyl ester. The retention time of Peak IV was 32.87 min, and standard 
 <italic>p</italic>‐coumaric acid ethyl ester was 32.81 min. Figure 
 <xref rid="fsn32004-fig-0002" ref-type="fig">2b</xref> shows the quasi molecular ion peaks of peak IV was 191.22 m/z [M‐H] 
 <sup>‐</sup>, indicating the molecular weight of 192 Dalton. Previous study reports that 
 <italic>p</italic>‐coumaric acid ethyl ester has the same molecular weight (Mussatto et al., 
 <xref rid="fsn32004-bib-0031" ref-type="ref">2006</xref>). Figure 
 <xref rid="fsn32004-fig-0002" ref-type="fig">2c</xref> shows the nuclear magnetic resonance analysis of peak IV. 
 <sup>1</sup>H NMR (400 MHz, CD
 <sub>3</sub>OD, δ, ppm, J/Hz) of peak IV:1.35 (3H, t, J = 8, CH
 <sub>3</sub>), 4.26 (2H, q, J = 4, 8, CH
 <sub>2</sub>), 6. 35 (1H, d, J = 16, H‐2), 6.84 (2H, d, J = 8.5, H‐3′, 5′), 7.48 (2H, d, J = 8, H‐2′, 6′), and 7.64 (1H, d, J = 16, H‐3) were found. Previous study reports the same characteristics of 
 <italic>p</italic>‐coumaric acid ethyl ester. Based on these results, the tyrosinase inhibition compound separated from peak IV was identified as 
 <italic>p</italic>‐coumaric acid ethyl ester (C
 <italic>
  <sub>p</sub>
 </italic>
 <sub>‐CAEE</sub> = 10μg/g).
</p>
